Arkeabio

Develops a methane-reducing vaccine for cattle to cut livestock emissions for farmers and food producers

+ Add to sales board

Highlights

  • New on EvolcAdded 2026-11-14

About Arkeabio

ArkeaBio is an agricultural bioscience company developing a vaccine that reduces methane emissions from cattle. The vaccine targets methane-producing microbes in the cow's rumen and is given as part of routine care, according to the company's product description.

The company positions the vaccine for cattle farmers, food producers, governments and consumers of beef and dairy. Its stated investors include Breakthrough Energy Ventures, which led a $12 million seed investment in 2022, along with Rabo Ventures, the Grantham Foundation and The51 Food & AgTech Fund.

ArkeaBio is headquartered in Charlestown, Massachusetts, where its site includes a 13,000 square foot lab. Its CEO is Frank Wooten. The careers page lists a general application as the open role.

Product: A methane-reducing vaccine for cattle, given as part of routine care to lower enteric emissions.

Jobs at Arkeabio

No open positions listed right now.

More biotech & pharma companies

  • Ascendis Pharma

    Biopharmaceutical therapies for patients with rare endocrine diseases and other medical needs
    United StatesBiotech & pharma40 open jobs
  • Asimov

    Genetic design software, engineered cells and DNA tools for biotechnology and therapeutics developers
    United StatesBiotech & pharma
    New on Evolc
  • Avalyn Pharma

    Clinical-stage biopharma developing inhaled drugs for rare lung diseases such as pulmonary fibrosis
    United StatesBiotech & pharma
    New on Evolc
  • Axiom

    AI drug-discovery platform that helps pharmaceutical scientists predict and mitigate toxicity before clinical development
    United StatesBiotech & pharma
    New on Evolc
  • Axsome Therapeutics

    Biopharma developing prescription medicines for psychiatric and neurologic brain disorders such as depression and migraine
    United StatesBiotech & pharma
    Growing
  • Beeline Medicines

    Clinical-stage biotechnology company developing oral precision therapies for people with autoimmune and inflammatory diseases
    United StatesBiotech & pharma1 open job
    Salary transparent

All biotech & pharma companies →

Website technologies

Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.

Analytics

  • Google Analytics 4High confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Content delivery

Content management

  • ElementorHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence
  • WordPressHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Frontend frameworks

  • jQueryHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Privacy & consent

  • TermlyHigh confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Recruiting

  • BambooHRMedium confidence
    First detected
    Last detected
    Last checked
    Detection evidence

Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.